Reduced expression of the E-cadherin gene and its aberrant DNA methylation in hamster pancreatic tumors

被引:15
|
作者
Shimizu, K
Hanaoka, M
Kato, A
Fujii, H
Honoki, K
Tsujiuchi, T
机构
[1] Kinki Univ, Fac Sci & Engn, Dept Life Sci, Lab Canc Biol & Bioinformat, Higashiosaka, Osaka 5778502, Japan
[2] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 6348521, Japan
关键词
pancreatic duct adenocarcinoma; DNA methylation; E-cadherin; hamster; nitrosamine;
D O I
10.1016/j.bbrc.2005.08.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of the E-cadherin gene and its DNA methylation status in the 5' upstream region were investigated in pancreatic duct adenocarcinomas (PDAs) induced by N-nitrosobis(2-oxopropyl)amine (BOP) in hamsters. Female Syrian golden hamsters received 70 mg/kg BOP, followed by repeated exposure to an augmentation pressure regimen consisting of a choline-deficient diet combined with DL-ethionine then L-methionine and a further administration of 20 mg/kg BOP. A total of 15 PDAs were obtained, along with total RNA for assessment of expression by real-time quantitative reverse transcription-polymerase chain reaction. The expression of the E-cadherin was significantly reduced in PDAs (p < 0.05) compared with normal pancreatic tissue. For the analysis of methylation status, bisulfite sequencing was performed with two normal pancreatic tissues and six tumors. The normal pancreatic tissue was all demethylated in this region of E-cadherin. In contrast, six PDAs were highly methylated, correlating with reduced expression of the E-cadherin. These results suggest that aberrant DNA methylation of the E-cadherin gene may play a role in the development of PDAs induced by BOP in hamsters. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [21] The Implications of E-cadherin Expression in Pancreatic Cancer
    Trofin, Ana Maria
    Lupascu, Cristian
    Spiridon, Irene Cianga
    Lupascu, Corina Ursulescu
    Zabara, Mihai
    Grigorean, Valentin
    Brasoveanu, Vladislav
    REVISTA DE CHIMIE, 2018, 69 (08): : 2291 - 2294
  • [22] Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer
    Karayiannakis, AJ
    Syrigos, KN
    Chatzigianni, E
    Papanikolaou, S
    Alexiou, D
    Kalahanis, N
    Rosenberg, T
    Bastounis, E
    ANTICANCER RESEARCH, 1998, 18 (6A) : 4177 - 4180
  • [23] The role of E-cadherin expression and E-cadherin gene promoter hypermethylation in gastric carcinoma
    Hamed, Mohamed K. F.
    Fawzy, Gamal
    Hanna, Hanna H.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (02): : 361 - 368
  • [24] Aberrant E-cadherin and γ-catenin expression in malignant mesothelioma and its diagnostic and biological relevance
    Orecchia, S
    Schillaci, F
    Salvio, M
    Libener, R
    Betta, PG
    LUNG CANCER, 2004, 45 : S37 - S43
  • [25] N-cadherin Expression in Feline Mammary Tumors Is Associated With a Reduced E-cadherin Expression and the Presence of Regional Metastasis
    Buendia, A. J.
    Penafiel-Verdu, C.
    Navarro, J. A.
    Vilafranca, M.
    Sanchez, J.
    VETERINARY PATHOLOGY, 2014, 51 (04) : 755 - 758
  • [26] Expression and Epigenetic Regulation of E-cadherin in Metastatic Gastrointestinal and Pancreatic Neuroendocrine Tumors and Carcinomas
    Lamzabi, Ihab
    Buckingham, Lela
    Jain, Richa
    Barbanera, William
    Singh, Rohit
    Jakate, Shriram
    Gattuso, Paolo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 : 105 - 105
  • [27] E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours
    Chen, CL
    Liu, SS
    Ip, SM
    Wong, LC
    Ng, TY
    Ngan, HYS
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (04) : 517 - 523
  • [28] Expression of E-Cadherin and uPA and its association with the prognosis for pancreatic cancer.
    Lee, KH
    Shin, SJ
    Kim, MK
    Hyun, MS
    Choi, J
    Song, HS
    Bae, SH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 357S - 357S
  • [29] Expression of the anhidrotic ectodermal dysplasia gene is reduced in skin cancer coinciding with reduced E-cadherin
    Montonen, O
    Ezer, S
    Laurikkala, J
    Karjalainen-Lindsberg, ML
    Thesleff, I
    Kere, J
    Saarialho-Kere, U
    EXPERIMENTAL DERMATOLOGY, 1998, 7 (04) : 168 - 174
  • [30] Expression and potential role of E-cadherin in pancreatic carcinoma
    Weinel, RJ
    Neumann, K
    Kisker, O
    Rosendahl, A
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 19 (01) : 25 - 30